Motley Rice HOME

Yasmin Lawyer

Women who took the oral contraceptive Yasmin® may be at risk for experiencing serious heart-related side effects. Motley Rice attorneys are currently reviewing Yasmin lawsuits involving women who are non-smokers and have experienced adverse side effects that may have been caused by Yasmin. A popular birth control pill manufactured by Bayer AG, Yasmin has been linked to serious heart-related health problems that include blood clots, heart attack and stroke.

In April 2012, the FDA announced that birth control pills such as Yasmin that contain the hormone drospirenone (synthetic version of the naturally occurring female hormone progesterone) will carry new labeling warning that these drugs may be more likely to cause blood clots than other types of birth control. The new labeling is based on recent studies that compared drospirenone-containing pills to low-dose estrogen pills. 

Contact Motley Rice

Contact a Yasmin Lawyer

Lawyers at Motley Rice are currently reviewing potential Yasmin lawsuits. If you or a loved one took Yasmin and suffered serious side effects such as heart attack or stroke, please feel free to contact Yasmin lawyer Carmen Scott by email or by calling 1.800.768.4036.

Yasmin Side Effects

Yasmin is prescribed to help prevent pregnancy in women who elect to use an oral contraceptive. The label for Yasmin cites numerous benefits linked to its use in addition to contraception but fails to adequately note the serious potential side effects of the drug that may include heart attack, blood clots and stroke. The FDA has cautioned the manufacturer about misleading marketing tactics that minimize serious Yasmin side effects and overstate the effectiveness of the drug. Yasmin side effects may include:

  • blood clots
  • death
  • deep vein thrombosis (DVT)
  • heart attack or myocardial infarction
  • pulmonary embolism
  • stroke

Yasmin Information

Yasmin is a contraceptive in pill form that was originally developed by Berlex Laboratories (a U.S. affiliate of the German company Schering AG) and approved in 2001 for use in the United States. In 2006, Bayer AG acquired Berlex Laboratories. Like other oral contraceptives, Yasmin contains a combination of the hormones estrogen and progestin. Yasmin contains 30mcg of ethinylestradiol, the estrogen component of the combination and the factor that differentiates it from a new version of the drug known as Yaz®, another Bayer AG contraceptive containing 20mcg.

Yasmin was the first type of birth control to contain the synthetic progestin, drospirenone, or drsp. Drospirenone may cause increased potassium levels, a side effect called hyperkalemia, in high-risk users. Potassium helps control cardiac rhythm, so hyperkalemia can cause rhythm disturbances. Drospirenone may also act as a diuretic and cause dehydration. Additional Yasmin side effects that may consequently result include:

  • death
  • gallbladder disease
  • kidney stones
  • renal failure

Because of these side effects and the increased risk for serious health problems, Yasmin is not recommended for women with renal insufficiency, adrenal insufficiency or hepatic dysfunction.